发明名称 |
Methods and compositions for the treatment of central nervous system disorders |
摘要 |
Disclosed is a pharmaceutical composition for treatment or prophylaxis of a central nervous system disorder for administration to a subject suffering from the disorder, comprising a compound of formula I that stimulates a nicotine receptor; either or both of at least one inhibitor of the AT2 receptor or at least one inhibitor of a substance that stimulates the AT2 receptor, and a pharmaceutically acceptable carrier.
|
申请公布号 |
NZ554913(A) |
申请公布日期 |
2009.01.31 |
申请号 |
NZ20020554913 |
申请日期 |
2002.12.13 |
申请人 |
TARGACEPT, INC;MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC |
发明人 |
BENCHERIF, MEROUANE;MARRERO, MARIO B |
分类号 |
G01N33/50;A61K31/44;A61K31/4406;A61K31/505;A61K45/00;A61P25/28;A61P43/00;C12Q1/02;C12Q1/48;G01N33/15;G01N33/94;(IPC1-7):G01N33/50;A61K31/440;A61P25/00 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|